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Aged garlic extract enhances paraoxonase 1 activity and 
suppress oxidative stress in CCl4- intoxicated rats
Abstract
The current study was undertaken to evaluate the hepatoprotective potential of aged garlic 
extract (AGE) against hepatotoxicity induced by CCl4 in adult male rats. CCl4 intoxication (1ml/
kg b.w., twice a week, i.p. for 4 weeks) significantly increased oxidative stress as indicated by 
increased hepatic MDA formation, decreased both serum total and reduced glutathione contents, 
and inhibition of hepatic glutathione reductase and serum paraoxonase 1(POX1) activities. In 
addition, treatment with CCl4 produced a significant increase in the activities of serum ALT, AST 
and albumin level with a significant decrease in total protein level. Moreover, treatment with CCl4 
resulted in significant increase in the levels of total cholesterol, LDL-cholesterol, triglycerides as well 
as creatine kinase isoenzyme and lactate dehydrogenase activities, and a significant decrease in 
HDL-cholesterol compared to control group. Oral treatment with AGE at doses of 100 and 200 mg/
kg/day in combination with CCl4 significantly ameliorated the severity of CCl4- induced changes in 
the above mentioned parameters in a dose- dependent manner. In conclusion, the present study 
indicated that AGE improves POX1 activity and attenuates liver and cardiac dysfunction induced 
by CCl4. The protective effects of AGE against CCl4 toxicity may be attributed to its antioxidant and 
free radical scavenging activities due to its higher contents of organosulphur compounds.
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Extrato envelhecido de alho incrementa a atividade de paraoxonase 1 e
suprime o estresse oxidativo em ratos intoxicados com CCl4-
Resumo
O presente estudo foi realizado para avaliar o potencial hepatoprotetor do extrato de alho 
envelhecido (AGE) contra hepatotoxicidade induzida por CCl4 em ratos machos adultos. CCl4 
intoxicação (1ml/Kg no peso corporal, duas vezes por semana, ip durante 4 semanas) aumentou 
significativamente o Estresse oxidativo, tal como indicado pelo aumento da formação de MDA 
hepática, diminuição tanto de soro total e conteúdo de glutationa, e inibição da atividade de 
glutationa redutase hepática e paraoxonase soro 1 (POX1 ). Além disso, o tratamento com CCl4 
produziu um aumento significativo nas atividades séricas de ALT, AST e nível de albumina com 
uma diminuição significativa no nível de proteína total. Ademais, o tratamento com CCl4 resultou 
num aumento significativo dos níveis de colesterol total, colesterol-LDL, triglicerídeos, bem como 
isoenzima creatina quinase e atividades da lactato desidrogenase, e uma diminuição significativa 
nos níveis de HDL-colesterol, se comparado com o grupo controle. O tratamento oral com AGE em 
doses de 100 e 200 mg / kg / dia em combinação com CCl4 demonstrou melhoras significativas na 
gravidade das alterações de CCl4 induzidas nos parâmetros acima mencionados, de uma maneira 
dose-dependente. Em conclusão, o presente estudo indicou que a idade aumenta a atividade 
de POX1 e atenua a disfunção no fígado e no coração induzidas por CCl4. Os efeitos protetores 
de idade contra a CCl4 toxicidade podem ser atribuídos aos seus antioxidantes e radicais livres, 
devido aos elevados teores de compostos organosulfurados.
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Introduction
 Plants used in traditional medicine for the 
treatment of liver disorders are of great interest, 
as they may serve as potential sources for new 
therapeutic agents that could be applied in 
the management and prevention of hepatic 
injury (Liu et al., 1995). Garlic (Allium sativum L., 
Alliaceae) originates from Central Asia and has 
been used universally as a flavoring agent and 
phytomedicine. The beneficial effects of garlic 
consumption in treating a wide variety of human 
diseases and disorders have been known for 
centuries. In ancient Egypt, it was used to promote 
general health and was mentioned in the Codex 
(Rahman, 2010).  In addition, garlic has the ability 
to act as an antioxidant (Chowdhury et al., 2008), 
antihypertensive (Silagy & Neil, 1994), antitumor 
(Galeone et al., 2009), hypolipidemic (Rahman, 
2010), hypocholesterolemic (Elmahdi et al., 2008) 
and antiatherosclerotic (Choudhary, 2008) agent. 
It also presents anticoagulant (Chan et al., 2007) 
and immunomodulatory (Chandrashekar & 
Venkatesh, 2009) properties. 
 Extensive studies carried out on garlic 
have reported the presence of two main 
classes of antioxidant components, namely 
flavonoids (Bozin et al., 2008) and sulfur-
containing compounds (diallyl sulfide, trisulfide 
and allyl-cysteine) (Kodera et al., 2002), which 
are believed to play an important role in the 
widely demonstrated biological effects of garlic, 
Nevertheless, Its impact on paraoxonase-1 (PON1) 
is remains obscure.
 Paraoxonase 1 (PON1) is a hydrolase 
enzyme located on HDL-cholesterol and has 
been postulated to play a protective effect 
on low density lipoprotein oxidation (Turk et al., 
2008). PON1 has also been reported to protect 
from oxidation and it is likely to be related to the 
high density lipoprotein antiapoptotic function, 
since the ability to protect against apoptosis is 
completely lost when the lipoprotein is oxidized 
(Krzystek-Korpacka et al., 2008). Liver plays a 
key role in the synthesis of PON1, as its gene of 
expression has been observed only in the liver 
(Leviev et al., 1997). The decrease in PON1 activity 
in chronic liver diseases is related to the degree 
of hepatic dysfunction not to allelic or genotypic 
differences (Marsillach et al., 2009). Also, it was 
suggested that there is an active role of PON1 
in the regulation of oxidative stress, fibrosis and 
hepatic cell apoptosis in chronic liver diseases 
(Ferré et al., 2006). 
 The aim of the present study was to 
evaluate the effects of chronic administration of 
AGE on PON1 in CCl4- intoxicated rats. The in vivo 
potential hepatoprotective effect of AGE against 
CCl4 -induced hepatotoxicity was detected 
by measuring the end product of hepatic lipid 
peroxidation, the activities of some hepatic and 
blood antioxidative enzymes and some markers 
of liver function. Also, the study was extended to 
shed light on the remodulating actions of AGE 
administration on some indices related to heart 
injury such as serum creatine kinase isoenzyme 
(CK-MB), lactate dehydrogenase (LDH) and lipid 
profile.
Material and Methods
Chemicals 
 Aged garlic extract (AGE) (Kyolic®) 
was purchased from Wakunaga of America 
Co. (Mission Viejo, CA, USA). It is prepared by 
soaking sliced raw garlic (Allium sativum) in 
15–20% aqueous ethanol for 20 months at room 
temperature. Carbon tetrachloride (CCl4) was 
obtained from SISCO Research Laboratories PVT 
LTD, Mumbai, India. All other chemicals used in 
the chemical methods were of reagent grade 
and were obtained from Sigma (Poole, Dorset, 
UK).
Animals and experimental design 
 Adult male albino Sprague Dawley rats 
were used throughout the present investigation. 
They were obtained from the animal house of 
the National Research Center, Dokki, Cairo, 
Egypt, and acclimatized for at least one week 
prior to the experiments. Animals were housed 
as groups in plastic cages with the condition of 
the experimental room. Animals were allowed 
free standard laboratory diet and drinking water 
ad libitum. All animals received human care in 
compliance with the guidelines of the Animals 
Care and Use Committee of National Research 
Centre, Egypt. 
 The used animals were divided into six 
groups (8 rats each) and treated for four weeks as 
follows: Group 1 was injected intraperitoneally with 
olive oil (1ml/kg b.w. twice a week) and served 
as control; Groups 2 and 3 were received AGE 
(dissolved in distilled water) orally in a single daily 
dose of 100 mg/kg b.w. (Fallon et al., 1998) and 
200 mg/kg b.w. (Sheen et al., 1999), respectively; 
group 4 was injected intraperitoneally with CCl4 
in olive oil (V/V) at a dose of 1ml CCl4 /kg b.w. 
(Luckey & Petersen, 2001) twice a week;  Groups 
5 and 6 were administered daily with AGE at a 
dose of 100 mg/kg b.w. and 200 mg/kg b.w., 
respectively, once daily in combination with CCl4 
injection (1ml CCl4 /kg b.w. twice a week).
Blood and tissue sampling
 After the end of the experimental period, 
rats were fasted for over night and the blood 
samples were collected from retroorbital venous 
plexus of the rats in all groups under diethyl 
ether anesthesia. Blood samples were left to clot 
then centrifuged at 3000 r.p.m for 15 minutes to 
separate the sera, which were stored at -20°C 
until biochemical analysis. After blood collection, 
all animals were rapidly killed and liver tissues were 
dissected and immediately homogenized in 50 
mM ice cold- phosphate buffer solution (pH 7.4) 
to give 20% (w/v) homogenate (Lin et al., 1998). 
The homogenate was centrifuged at 3000 r.p.m 
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at 0°C for 10 minutes and the supernatant was 
used for the determination of malondialdehyde 
(MDA) and glutathione reductase activity (GR). 
Analytical determinations
 Serum aspartate aminotransferase (AST) 
and alanine aminotransferase (ALT) activities were 
determined colorimetrically using kits purchased 
from Randox Laboratories LTD Co., UK. Total protein 
and albumin concentrations were determined 
in serum using kits produced by Biodiagnostic 
Co., Cairo, Egypt. Globulin concentration was 
calculated by subtracting the concentration 
of albumin from the concentration of the total 
protein. Lipid peroxidation in liver homogenate was 
estimated by measurement of malondialdehyde 
(MDA) by the spectrophotometric method of 
Ruiz-Larnea et al. (1994). Determinations of total 
glutathione (tGSH) and reduced glutathione 
(rGSH) concentrations in serum were carried out 
following the methods described by Saville (1958) 
and Prins & Loose (1969), respectively. The oxidized 
glutathione (oxGSH) in serum was calculated 
by subtracting the concentration of rGSH from 
the concentration of tGSH. Serum paraoxonase 
(PON1) activity was determined according to the 
kinetic spectrophotometric method described 
by Eckerson et al. (1983). Glutathione reductase 
(GR) activity in liver homogenate was determined 
using a kit purchased from Oxis ResearchTM Co., 
USA. Colorimetric determinations of serum levels 
of triglycerides, total cholesterol, high density 
lipoprotein cholesterol (HDL-c) and low density 
lipoprotein cholesterol (LDL- c) were assayed using 
kits produced by Sentinel CH, Milan, Italy. Kinetic 
determinations of CK-MB and LDH activities were 
carried out using kits purchased from Centronic 
GmbH, Germany and Teco Diagnostic, CA, USA, 
respectively.
Statistical analysis
 The obtained data were subjected to one 
way analysis of variance (ANOVA); correlation 
analysis was also performed. All analyses were 
performed using statistical analysis system (SAS) 
program software; copyright (c) 1998 by SAS 
Institute Inc., Cary, NC, USA. Tukey test was used 
to clarify the significance between the individual 
groups at probability level P< 0.01 (Steel & Torrie, 
1980).
Results
 The effects of daily aged garlic extract 
(AGE) intake on the markers of liver function in 
CCl4 - intoxicated rats are presented in table (1). 
CCl4 treatment resulted in significant increase 
in ALT and AST activities (P< 0.01) compared to 
the control group. At the same time, it caused 
significant decrease (P< 0.01) in the level of 
serum total protein with a significant elevation 
in albumin level but did not affect globulin level. 
The administration of AGE to rats succeeded in 
ameliorating significantly, in a dose dependent- 
manner, the CCl4–induced changes in the 
mentioned parameters.
 As shown in table (2), CCl4 intoxication 
significantly increased MDA and oxGSH formation, 
lowered serum levels of tGSH and rGSH, and 
lowered hepatic GR and serum PON1 activities; 
however, the intake of AGE in combination 
with CCl4 significantly lowered MDA formation, 
alleviated GSH depletion, and enhanced GR and 
PON1 activities (P< 0.01, as compared with CCl4 – 
treated group). 
Table 1. Serum markers of liver function in different studied groups.
Group
Parameter
Control AGE (100 mg/kg)
AGE 
(200 mg/kg)
CCl4
(1ml/kg)
AGE 
(100 mg/kg)
+ CCl4
AGE
 (200 mg/
kg) +  CCl4
ALT (IU/l) 61.5±1.84D 63±1.97 D 58±1.87 D 154±4.19 A 100±3.15 B 81±2.54 C
AST (IU/l) 122±1.80 D 120±1.73 D 119±1.81 D 453±10.38 A 297±7.94 B 202±5.35 C
T.Proteins (g/dl) 7.56±0.12 A 7.39±0.12 A 7.24±0.12 A 6.77±0.10 C 7.15±0.12 AB 7.30±0.11 AB
Albumin (g/dl) 3.67±0.08 A 3.59±0.06 A 3.46±0.05 A 3.15±0.11 B 3.49±0.07 A 3.56±0.08 A
Globulin (g/dl) 3.89±1.57 A 3.80±0.10 A 3.78±0.07 A 3.62±0.13 A 3.66±0.13 A 3.74±0.14 A
Values are mean ± SE for 8 rats per group. Within each row, means with different letters are significantly different (P < 0.01) using one way (Tukey) ANOVA test.
Table 2. Oxidant-antioxidant status in different studied groups.
Group
Parameter
Control AGE (100 mg/kg)
AGE 
(200 mg/kg)
CCl4
(1ml/kg)
AGE 
(100 mg/kg)
+ CCl4
AGE
 (200 mg/
kg) +  CCl4
L.MDA (nmol/g liver) 28.1±0.37D 26.8±0.63D 24.1±0.57D 64.88±0.99 A 45.13±0.69 B 35.13±1.65C
S. tGSH (nmol/ml) 12.36±0.22A 11.72±0.21AB 12.07±0.24A 8.05±0.44D 9.61±0.17C 10.44±0.19BC
S. rGSH (nmol/ml) 7.95±0.09 A 8.26±0.14A 8.20±0.19A 2.32±0.25D 5.14±0.17C 7.31±0.18B
S.oxGSH (nmol/ml) 4.41±0.21B 3.46±0.25 BC 3.87±0.12BC 5.73±0.27 A 4.47±0.21B 3.12±0.15C
L.GR (mU/g liver) 290±10.23AB 294±3.97AB 311±7.31A 249±4.64 C 262±4.58BC 298±5.56A
S.PON1 (IU/l) 629±10.38AB 650±10.70AB 668±12.52A 474±17.78D 541±8.92C 603±9.90B
Values are mean ± SE for 8 rats per group. Within each row, means with different letters are significantly different (P < 0.01) using one way (Tukey) ANOVA test. L: liver; S: serum; GR: 
glutathione reductase; GSH: glutathione.
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 The effects of AGE and CCl4 on some 
parameters of lipid profile are depicted in table (3).
The data show that treatment with CCl4 resulted in 
significant (P< 0.01) increases in total cholesterol, 
LDL-c, triglycerides levels as well as LDL/HDL ratio, 
and a significant (P< 0.01) decrease in HDL-c level 
compared with the control group.. Co-treatment 
with AGE and CCl4 resulted in a significant 
protection of these parameters against the above 
mentioned effects of CCl4.  Meanwhile, the high 
dose of AGE (200 mg/kg b.w.) was found to be 
more effective in normalizing the markers of lipid 
profile in CCl4 - treated rats. On the other hand, 
the activities of CK-MB and LDH were significantly 
increased by CCl4 treatment (Table 4, P< 0.01); 
and AGE administration significantly reduced 
CK-MB and LDH activities (P< 0.01) towards the 
normal values of the controls. 
 The present work (Table 5) declared 
that serum PON1 activity correlates inversely 
with serum ALT, AST activities, serum triglycerides, 
total cholesterol, LDL-c, oxGSH and hepatic MDA 
levels; and correlates directly with serum HDL-c, 
total proteins, rGSH and hepatic GR activity.
Table 3. Serum total cholesterol, triglycerides, HDL-c and LDL-c levels in different studied groups.
Group
Parameter
Control
AGE
 (100 mg/
kg)
AGE 
(200 mg/kg)
CCl4
(1ml/kg)
AGE 
(100 mg/kg)
+ CCl4
AGE
(200 mg/kg)
+ CCl4
T.Chol (mg/dl) 58.88±1.78C 56.53±1.71C 53.58±1.62C 92.27±4.11A 75.34±3.39B 65.23±2.93BC
Trigl (mg/dl) 33.80±1.58C 32.45±1.11C 30.76±1.05C 64.22±2.19A 52.02±1.78B 46.88±1.60B
HDL-c (mg/dl) 19.85±0.59BC 21.42±0.68A 24.39±0.80B 14.09±0.43E 15.80±0.45DE 17.41±0.57CD
LDL-c (mg/dl) 32.28±2.13C 28.68±1.95C 26.50±2.19C 64.94±4.21A 49.14±3.33B 38.45±3.08BC
LDL-c/HDL-c 
ratio 1.65±0.14
CD 1.31±0.11CD 1.86±0.10D 4.63±0.31A 3.12±0.20B 2.23±0.20BC
Values are mean ± SE for 8 rats per group. Within each row, means with different letters are significantly different (P < 0.01) using one way (Tukey) ANOVA test.
Table 4. Serum lactate dehydrogenase (LDH) and creatinine kinase (CK-MB) activities in different studied groups.
Group
Parameter
Control
AGE
 (100 mg/
kg)
AGE 
(200 mg/kg
CCl4
(1ml/kg)
AGE 
(100 mg/kg)
+ CCl4
AGE
(200 mg/kg)
+ CCl4
LDH (IU/l) 393±3.97D 320±3.8 7D 390±5.97D 846±8.49A 643±6.47B 465±13.04C
CK-MB (IU/l) 491±33.99C 478±33.12C 454±31.47C 821±16.29A 691±13.63B 531±10.49C
Values are mean ± SE for 8 rats per group. Within each row, means with different letters are significantly different (P < 0.01) using one way (Tukey) ANOVA test
Table 5. The statistical correlation coefficient (R) between PON 1 activity and other parameters.
Correlation R  value P value
PON 1
ALT - ve -0.97644 0.1385
AST - ve -0.71836 0.4898
T. protein + ve 0.58795 0.5999
L. MDA - ve -0.99236 0.0787
tGSH + ve 0.92188 0.2533
rGSH + ve 0.96334 0.1729
oxGSH - ve -0.81087 0.3980
L.GR + ve 0.98881 0.0953
Cholesterol - ve -0.99783 0.0420
Triglyceride - ve -0.98572 0.1077
HDL-c + ve 0.93666 0.2278
LDL-c - ve -0.99993 0.0078
LDH - ve -0.95882 0.1833
CK - ve -0.53365 0.6416
Discussion
 Liver injury can be caused by toxic 
chemicals, drugs, and virus infiltration from 
ingestion or infection. Carbon tetrachloride 
(CCl4) has been widely used in animal models 
to investigate chemical toxin-induced liver 
damage. The most remarkable pathological 
characteristics of CCl4-induced hepatotoxicity 
are fatty liver, cirrhosis and necrosis, which have 
been thought to result from the formation of 
reactive intermediates such as trichloromethyl 
free radicals (CCl·3) metabolized by the mixed 
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function of cytochrome P450 in the endoplasmic 
reticulum (Wang et al., 2008). Therefore one of the 
therapeutic strategies against liver injury is to find 
antioxidant compounds that are able to block 
liver injury through scavenging of trichloromtheyl 
free radical generated by CCl4.  
 The present results showed that CCl4 
causes significant increases in ALT and AST values 
which are cytoplasmic in location and are 
released into circulation after cellular damage 
so the increase in this enzyme may be attributed 
to the damage in the structural integrity of 
the liver (Recknagel et al., 1991). Similar to 
the present results, Bhattacharjee & Sil (2007) 
reported that CCl4 administration to rats or mice 
caused hepatotoxicity, which is accompanied 
by elevations of ALT and AST enzymes. The 
hypofunction of the liver was further confirmed 
in the present study by the decrease in serum 
total protein level accompanied by increases 
in albumin level and albumin/globulin ratio. 
CCl4 as a xenobiotic induces lipid peroxidation 
(LP) and toxicity (Jeon et al., 2003). It is well 
established that CCl4 is metabolized in the liver to 
highly reactive trichloromethyl radical (CCl·3) by 
the activation of cytochrome P450. CCl·3 and its 
highly reactive derivative, the trichloro- methyl 
peroxyl  radical (CL3Coo), are assumed to initiate 
free radical – mediated LP of the cytoplasmic 
membrane phospholipids causing functional and 
morphological changes in the cell membrane 
leading to accumulation of lipid – derived 
oxidants and liver injury (Badger et al., 1996). 
The peroxidation process has been suggested to 
result in the release of soluble products that may 
affect cell membrane. Cell membranes integrity 
is broken and enzymes in the cell plasma leak out 
(Martin-Aragon et al., 2001). This may explain the 
increase in the activities of ALT and AST in serum of 
CCL4-treated group. 
 In the present study, hepatic 
malondialdehyde (MDA) was found to be 
significantly higher in animals treated with CCl4 
alone. It has been shown that lipid peroxides are 
not only noxious to the living organism, but also 
some of their stable breakdown products such as 
MDA have been recognized to cause some cell 
alterations by modifying protein structure. The 
reaction between MDA and the primary amino 
groups of proteins forms Schiff base compounds, 
which give rise to intra and intermolecular linkages 
which can lead to polymerization and inactivation 
of enzymes. In addition, MDA reactivity towards 
amino groups can result in inhibition of DNA and 
RNA protein synthesis (Sreenivas Rao et al., 2004). 
So the decreased total protein in CCl4 treated 
group may be due to the liver damage caused 
by CCl4 which may affect protein synthesis. 
 Alterations in hepatic antioxidant status 
may therefore manifest oxidative stress caused 
by CCl4 and its metabolites. The CCl4-induced 
escalation of lipid peroxidation in the liver might 
be a consequence of increased formation of free 
radicals as well as the inhibition of the activities 
of antioxidant enzymes such as glutathione 
reductase. The results obtained indicate 
that at the used level of CCl4 treatment, the 
antioxidant defense system in the liver and serum 
was insufficient to give complete protection 
against lipid peroxidation. This might result from 
the fact that the liver is the main site of CCl4 
biotransformation and at the same time the main 
site of free radicals formation. 
 CC14 treatment increased serum 
triglyceride, total cholesterol, LDL- c and LDL/HDL 
values but decreased HDL- c level. These results 
are in agreement with those recorded by Torres-
Durán et al. (1998). Cholesterol concentrations 
are determined by metabolic functions, which 
are influenced by integrity of vital organs 
such as the liver and kidney (Marcus & Milton, 
1982). The elevation of triglycerides level may 
be due to impaired removal and destruction of 
triglycerides rich in lipoproteins such as very low 
density lipoprotein, low density lipoprotein and 
remnants (Recknagel & Lombardi, 1961), resulting 
in increased plasma levels of very low density 
lipoprotein triglycerides (Ginsberg & Grundry 1982), 
which is a risk factor in atherorclerosis.  Extrahepatic 
lipoprotein lipase such as in the heart is involved in 
the uptake of triglycerides rich lipoproteins from 
the circulation (Nestel et al., 1963). Hyperlipidemia 
and lipoprotein abnormalities (Rahman, 2010) 
and oxidative stress (Jayakumar et al., 2008) are 
well-established risk factors in heart disease. This 
suggestion asserted the increment in both serum 
CK-MB and LDH recorded in the current study. 
Theoretically, CK-MB is a marker of heart failure. 
The mechanism for the release of this marker 
seems to be from ventricular remodeling, ongoing 
myocyte degenera tion, the presence of coronary 
artery disease and reduced coronary reserve 
(Potluri et al., 2004). LDH is an enzyme found in 
the cytoplasm of almost all body tissues, where 
its main function is to catalyze the oxidation of 
l-lactate to pyruvate. It is assayed as a measure 
of anaerobic carbohydrate metabolism and as 
one of several serum indicators of myocardial 
infarction (Piccone et al., 1995).
 The present data revealed a significant 
decrease in serum PON1 activity of CCl4- 
intoxicated rats. Liver plays the key role in the 
synthesis of serum PON1, and the gene expression 
has been observed only in the liver (Leviev et al., 
1997) thus, the decrease in PON1 activity here 
may be due to the hepatic dysfunction induced 
by CCl4 toxicity. As PON1 is known to be tightly 
bound with HDL-c, therefore, the decrease in 
PON1 activity could be a consequence of an 
altered synthesis and/or secretion of HDL-c. 
Alterations in HDL-c structure and concentration 
associated with decreases in hepatic lecithin 
cholesterol acyl transferase activity are frequent 
in chronic liver diseases (Sabesin et al., 1997). 
Moreover, the disulfide bond (cys-42 and cys-
353), in PON1 molecule, was found to be essential 
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for its activity; while the free thiol (cys-284) was 
not; this suggesting that cys-284 is the active 
site responsible for the antioxidant property of 
PON1 (Josse et al., 2002). The highly reactive free 
radicals produced by CCl4 metabolism can react 
with sulfhydryl groups, such as glutathione and 
protein thiols (Brattin et al., 1985), and it was stated 
that there is a close association between PON1 
antioxidant activity and the number of –SH groups 
within PON1 (Jaouad et al., 2006), therefore the 
reduction in PON1 antioxidant activity might be 
due to an alteration in nature and number of free 
thiol groups in its molecule. 
 The hepatoprotective effects of aged 
garlic extracts (AGE) were demonstrated in the 
current study by restoring the activities of serum 
ALT and AST enzymes that were significantly raised 
by CCl4 administration. These results indicated 
that AGE has membrane stabilizing effect. This 
effect may be attributed to the ability of AGE 
to protect the liver tissues from free radical-
mediated toxic damages and reduction of the 
oxidative stress through decreased hepatic 
MDA of CCl4-intoxication rats. Our present study 
agreed with the previous study of Hsu et al. (2006) 
which indicated that the water soluble S-allyl 
cysteine component of garlic alleviates ALT and 
AST enzymes and suppress lipid peroxidation in 
acetaminophen-induced endothelial dysfunction 
and haemostatic disorder in mice. On the other 
hand, AGE administration could increase serum 
total protein by preventing protein oxidation 
which probably reflects the potential ability of 
AGE to improve protein synthesis and increasing 
the immunoglobulin and globulin concentrations 
(Hassan et al., 2010). 
 The results of the present study indicate 
that serum tGSH, rGSH levels and hepatic GR 
activity were significantly decreased and the 
oxGSH is increased in response to CC14 treatment 
alone compared with control rats implying 
increased oxidative damage to the liver. On the 
contrary, the antioxidants values were significantly 
elevated by administration of   AGE.
 The present results demonstrated that 
the possible hepatoprotective mechanisms of 
AGE on CCL4- induced liver damage in rats might 
be due to either inhibiting the cytochrome P 450 
– dependant oxygenase activity, preventing 
lipid peroxidtion or stabilizing the hepatocyte 
membrane. Garlic contains a number of 
organosulphur compounds which are generally 
believed to be the active constituents responsible 
for its biological actions (Agarwal, 1996). These can 
be divided into water-soluble compounds such as 
S-allyl cysteine and oil-soluble compounds such 
as diallyl sulphide. The aged garlic extract that we 
have used is prepared by slicing fresh garlic and 
soaking it in dilute ethanol for 20 months at room 
temperature. This process is supposed to cause 
increased activity of certain new generated 
compounds like S-allyl cysteine (SAC), S-allyl 
mercaptocysteine (SAMC), allixine and selenium 
which are stable and highly bioactive (Rahman & 
Billington, 2000).    
 It is well understood that rGSH is an 
important cellular antioxidant that is capable 
of direct or indirect (via glutathione peroxidase) 
conjugation with reactive oxygen species such 
as lipid hyperperoxides and hydrogen peroxide 
(Meister, 1983). In contrast to the toxic activation of 
CC14 via the cytochrome P450 2E1 pathway, the 
detoxification pathway involves rGSH conjugation 
of the trichloromethyl radical, a cytochrome P450 
2E1 – mediated CC14–metabolite (Recknagel et 
al., 1991). rGSH is largely mediated through the 
activity of glutathione S-transferase (GST), and 
forms adducts with the toxic metabolites of CC14. 
Moreover, rGSH contributes to the detoxification 
of CC14, and it has been suggested that one of 
the principle causes of CC14 – induced liver injury 
is lipid peroxidation caused by its free radical 
derivatives (Recknagel et al., 1991).
  The mechanism by which treatment of rats 
with AGE increases the hepatic content of rGSH 
may involve either increased synthesis and /or 
decreased utilisation. It is doubtful that decreased 
rGST activity could account for decreased 
utilisation; indeed, the garlic constituent's S-allyl 
cysteine (SAC) (Hatono et al., 1996) have been 
shown to induce some isoforms of GST in liver. 
Alternatively, Hsu et al. (2004) proposed that SAC, 
and S-propyle cysteine (SPC) and other cysteine 
related compounds such as S-methyl cysteine and 
S-ethyl cysteine that derived from garlic may act 
as precursors of rGSH and stimulate rGSH synthesis. 
In previous studies, the intake of SAC and SPC was 
reported to increase rGSH retention in organs and 
blood, which consequently elevated glutathione 
peroxidase and/or catalase activities and 
suppressed oxidative stress presented in normal 
and diabetic mice (Hsu et al., 2004) and alleviate 
acetaminophen-induced depletion of rGSH 
content in blood and organs, and consequently 
they reduced oxidative damage in blood and 
liver (Hsu et al., 2006).  
 Additionally, there is growing evidence that 
the hepatoprotective effect of AGE takes place 
directly at the level of hepatocytes by inhibiting 
cytochrome P450 2E1 activity (Sumioka et al., 1998). 
The toxicity of CCl4 results from its bioactivation to 
the toxic metabolite trichloromethyl radical via 
cytochromes P450 2E1 (Recknagel et al., 1991). 
The protective effect of garlic may be due, at 
least in part, to inhibition of this bioactivation since 
some garlic constituents inhibit the 2E1 isoform of 
cytochrome P450 (Lin et al., 1996). 
 The decrease in the levels of serum total 
cholesterol, LDL-c and triglyceride combined 
with significant elevation in serum HDL-c level in 
AGE treated groups may be attributed to the 
water soluble organosulfur compounds of AGE 
(Gebhardt, 1993) that can inhibit key enzymes 
in lipid synthesis. In addition, AGE protects liver 
from oxidative stress and protein deficiency. This 
in turn improves liver function and consequently 
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improves lipid metabolism. The normalization of 
abnormal lipids, lipoproteins, and hypertension, 
inhibition of platelet aggregation, and an 
increase in antioxidant status are believed to 
improve heart disease (Rahman, 2010). This may 
confirms the improvement in CK-MB and LDH 
values that were observed in AGE groups in our 
study. Our results were asserted by the finding 
of Alkreathy et al. (2010) who demonstrated a 
significant decrease in the cardiac MDA level 
with concomitant decrease in serum CK and LDH 
activities by treatment with AGE in doxorubicin-
induced cardiotoxicity in rats.
 Rosenblat et al. (2006) stated that 
intervention, means including the use of potent 
antioxidants of different sources, may be increase 
PON1 activity.  AGE able to prevent free radical 
from reaching biomolecules in susceptible 
biological systems and improve HDL-c, this 
besides to its antioxidant characteristics exhibited 
by its organosulfur compounds (Gebhardt, 1993). 
Many, in vitro and in vivo, studies have provided 
initial evidence that antioxidants can increase 
PON1 activity possibly by protecting the enzyme 
from oxidative stress (Aviram et al., 1999; Aviram 
et al., 2000).  PON1, an HDL-associated enzyme 
synthesized in the liver and secreted into the blood 
(Sabesin et al., 1997). So, the high PON1 activity 
found in our AGE groups could be asserted also 
by the significant positive correlation that was 
found between PON1 activity and HDL-c level. 
Conclusions
 In conclusion, the present study showed 
that AGE attenuate the hepatic dysfunction 
induced by CCl4 as indicated by decreasing both 
GPT and GOT; and normalizing PON1 activity as 
well as lipid peroxidation reaction and its related 
biochemical changes. The protective effects 
of AGE against CCl4-induced liver toxicity may 
be attributed to its antioxidant and free radical 
scavenging activities due to its higher contents of 
organosulphur compounds.
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